Sign In | Join Free | My frbiz.com
frbiz.com
Products
Search by Category
Home >

cTnI Cardiac Detection POCT Instrument 740nm Dry Fluorescence Immunoassay Analyzer

Categories POCT Instrument
Brand Name: WWHS
Model Number: NIR--1000
Certification: ISO 13485, CE
Place of Origin: CN
MOQ: 2
Price: Negotiable
Payment Terms: T/T, L/C
Supply Ability: 60 Sets per Day
Delivery Time: 10 Days
Packaging Details: Carton
Product Name: Dry Fluoroimmunoassay Analyser
Condition: 2021 New
Work Temperature: 5-40℃
Net Weight: 2.0 KGS
Touch Screen: 7" LCD Display
Volume: 200×300×140mm
Wavelength Range: 740nm
Test Item: NIR-1000 is used cooperatively with immunofluorescence assay kits produced by WWHS
Quality Inspection Card: 1 piece
Manufacturer: WWHS Biotech INC
  • Haven't found right suppliers
  • Our buyer assistants can help you find the most suitable, 100% reliable suppliers from China.
  • And this service is free of charge.
  • we have buyer assistants who speak English, French, Spanish......and we are ready to help you anytime!
Submit Buying Request
  • Product Details
  • Company Profile

cTnI Cardiac Detection POCT Instrument 740nm Dry Fluorescence Immunoassay Analyzer

WWHS NIR-1000 Dry Fluorescent Immunoassay Analyser For cTnI Cardiac Detection


The cTnI (Cardiac troponin I) Rapid Quantitative Test along with WWHS Fluorescence Immunoassay Analyzer is intended for vitro quantitative determination of Cardiac troponin I (cTnI) in human whole blood, serum or plasma. It is mainly used for auxiliary diagnosis of myocardial infarction.


Description of WWHS NIR-1000 Dry Fluoroimmunoassay Analyser

High Accuracy

When the instrument tests the calibrated fluorescence test card, the deviation between the measured fluorescence value and the calibration value of the fluorescence test card is ±3.0%.

Repeatability

The variable coefficient of fluorescence value of fluorescence test cards of different intensities repeatedly measured by the instrument CV≤2.0%



WWHS Assay List


Cardiac     
cat#.Product itemSpecimenReaction TimeMeasure RangeClinical RangeItended Use
1cTnIWB/Serum/Plasma12min.0.1-40ng/ml<0.3ng/mlseveral heart diseases including myocardial infarction and heart failure.
2MyoWB/Serum/Plasma12min.5-400ng/ml<58ng/mlacute myocardial infarction (AMI) in early stage.
3CK-MBWB/Serum/Plasma12min.1-200ng/ml<5ng/mlacute myocardial infarction (AMI) in early stage.
4NT-proBNPWB/Serum/Plasma10min.20-35000pg/mlUnder 75:0~347pg/mL,
Over 75:0~449pg/mL
heart failure .
5D-DimerWB/Plasma10min.40-10000ng/ml<500ng/mldisseminated intravascular coagulation (DIC),deep vein thrombosis (DVT),pulmonary embolism (PE), myocardial infarction, cerebral infarction, etc.
6cTnI+Myo+CKMBWB/Serum/Plasma12min.same with single itemsame with single itemTriple marker of myocardial infarction.
7ST2WB/Serum/Plasma10min.10-400ng/ml<35ng/mlheart failure .
8Lp-PLA2WB/Serum/Plasma10min.10-900ng/ml<175ng/mlRisk evaluation of ACS and atherosclerotic ischemic stroke patients.
9S100-βWB/Serum/Plasma10min.0.05-10ng/ml<0.2ng/mlCerebral infarction, cerebral injury.
Inflammation     
10CRP / hs-CRPWB/Serum/Plasma3min.0.5-200mg/LCRP<10mg/L,hs-CRP<1mg/Lnonspecficity inflammatory marker.
11SAASerum5min.1-200mg/L<10mg/Linflammation&infection.
12PCTWB/Serum/Plasma10min.0.2-100ng/ml<0.5ng/mlSepsis
13CRP+SAAWB/Serum/Plasma5min.same with single itemsame with single iteminflammation&infection.
14IL-6WB/Serum/Plasma10min.5-4000pg/ml10pg/mldiabetes,rheumatoid arthritis,etc
Thyroid Hormone     
15TSHSerum/Plasma15min.0.3-100mU/L0.35-5mU/Lhyperthyroidism and hypothyroidism
16TT3Serum/Plasma15min.0.5-10nmol/L1.3-3.1nmol/Lthyroid dysfunction
17TT4Serum/Plasma15min.5-300nmol/L66-181nmol/Lthyroid dysfunction
18FT3Serum/Plasma15min.1-100pmol/L4-10pmol/Lthyroid dysfunction
19FT4Serum/Plasma15min.5-300pmol/L19-39pmol/Lthyroid dysfunction
Tumor Marker     
20AFPSerum/Plasma15min.2.5-200ng/ml<20ng/mlpregnancy cancer
21CEASerum/Plasma15min.1-200ng/ml<5ng/mlcolon cancer, colorectal cancer,etc.
22NSESerum/Plasma15min.1-400ng/ml<16ng/mlnon-small cell lung cancer
23FOBfecal specimens10min.50-1000ng/ml<100ng/mlAbnormal recessive gastrointestinal bleeding
24PG IISerum/Plasma15min.1-100ug/LPGI/PGII>3.0gastric abnormalities
25PG ISerum/Plasma15min.2.5-200ug/L>70ng/mlgastric abnormalities
26TPSASerum/Plasma15min.0.5-40ng/ml<4ng/mlprostate cancer
27FPSASerum/Plasma15min.0.1-10ng/ml<1ng/mlprostate cancer
28CA12-5Serum/Plasma15min.20-500U/ml<35U/mlovarian cancer
29CA15-3Serum/Plasma15min.10-400U/ml< 25 U/mLbreast cancer
30HE4Serum/Plasma15min.50-2000pmol/L<140 pmol/Lovarian cancer
31CA19-9Serum/Plasma15min.10-400U/ml< 27 U/mLpancreatic cancer
32β-HCGSerum/Plasma15min.5-400mIU/ml<10 mIU/mLEarly pregrancy, ectopic HCG cancer,incomplete abortion
33CK19(Cyfra21-1)Serum/Plasma15min.0.5-50ng/ml<2.5ng/mlnon-small cell lung cancer
Fertility     
34HCG / β-HCGSerum/Plasma10min.5-20000mIU/ml<5 mIU/mLearly pregrancy.
35AMHSerum/Plasma10min.0.1-16ng/mlMale: 20-60 years old, 0.92-13.89 ng/mL
Female: 20-29 years old, 0.88-10.35 ng/mL
30-39 years old, 0.31-7.86 ng/mL 40 -50 years old, <5. 07 ng/mL
ovarian reserve level
Gastrointestinal      
36FOBfecal specimens10min.qualitativequalitativegastrointestinal hemorrhage.
37TRFfecal specimens10min.qualitativequalitativegastrointestinal hemorrhage.
38FOB+TRFfecal specimens10min.qualitativequalitativegastrointestinal hemorrhage.
Infection      
39C.PneumoniaWB/Serum/Plasma15min.qualitativequalitativeCP infection
40M.PneumoniaWB/Serum/Plasma15min.qualitativequalitativeMP infection
41Covid-19 Antigennasal swab, throat swab or nasal wash/aspirate specimens15min.qualitativequalitativerespiratory tract
42Covid-19 Ab IgG/IgMWB/Serum/Plasma15min.qualitativequalitativerespiratory tract
43FluAnasal swab, throat swab or nasal wash/aspirate specimens15min.qualitativequalitativerespiratory tract
44FluBnasal swab, throat swab or nasal wash/aspirate specimens15min.qualitativequalitativerespiratory tract
Renal Injury      
45CysCWB/Serum/Plasma5min.0.4-9mg/L0.5-1.1mg/Lrenal function
46NGALUrine10min.10-1500ng/mL<132ng/mLacute kidney injury.
Other      
47FERRSerum5min.10-500ng/mlMale:24ng/mL~335ng/mL,
Female:11ng/mL~307ng/mL
iron metabolism related diseases, such as hemochromatosis and iron deficiency anemia
48HbA1cWB10min.4%-14%4%-6%diabetes
49VDSerum/Plasma15min.8-70ng/mL19-57ng/mLfetation

About NIR-1000 Dry Fluoroimmunoassay Analyser


It is a fluorescence immunochromatographic analysing system with internal temperature

control,

which can help diagnose conditions such as infection, diabetes, cardiovascular diseases,

renal injury and cancers, etc.

Immunofluorescence technology

Testing time less than 15 minutes

Easy-to-use touch-screen platform,multi-language system

Reagents stored at room temperature for 12 months


Product Features


1 Wide-Range Diagnostics, It can be used in following areas:

1) Department of thoracic Surgery

2) Clinical Laboratory

3) Department of Emergency

4) First Aid Community Hospital

5) Department of Respiration

6) CCU/ICU

7) Department of cardiology

8) Department of Geriatrics


2 Simple Procedure To Operate

1) Sample Can Be Plasma&whole Blood

2) Choose Internal Or External According To Needs

3) Single&Batch Processing

only two simple steps: Add 100ul blood sample to the test strip and wait for 15 minutes, then insert the test strip into the device and get the results


Quality cTnI Cardiac Detection POCT Instrument 740nm Dry Fluorescence Immunoassay Analyzer for sale
Send your message to this supplier
 
*From:
*To: WWHS Biotech.Inc(exclusive marketed by Dawin)
*Subject:
*Message:
Characters Remaining: (0/3000)
 
Inquiry Cart 0